Strengthening the financial position and transitioning to a stage of management stability
First written in FY2016. 9 of 27 entries say "Advanced", first in FY2018. Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026WorsenedAnnual report
「Net sales were ¥17,809 million, down 1.4% from the previous fiscal year. Operating income declined 63.9% to ¥483 million, and ordinary income fell 59.3% to ¥600 million.」
Following record-high sales and lower profit in the previous fiscal year, the decline in sales widened in the current fiscal year, while operating income and ordinary income also fell sharply. - FY2026-H1Higher sales but lower profitAnnual report
「As a result, consolidated results for the first half were as follows. Net sales rose 0.9% year on year to ¥8,134 million. On the profit side, the cost of sales ratio increased due mainly to higher labor costs, and research and development expenses also increased. Operating income therefore declined 50.5% to ¥158 million, ordinary income fell 53.7% to ¥188 million, and interim net income attributable to owners of the parent decreased 34.3% to ¥172 million.」
While net sales increased 0.9% year on year, operating income, ordinary income and interim net income declined, resulting in higher sales but lower profit. - FY2025Record-high sales alongside lower profitAnnual report
「As a result, net sales for the fiscal year rose 3.5% to ¥18,058 million, a record high. On the profit side, the cost of sales increased due to labor costs, relocation associated with consolidation into the new production building and overseas certification testing. Selling, general and administrative expenses also increased due to higher personnel and research and development costs. Consequently, operating income declined 24.3% to ¥1,338 million, and ordinary income fell 20.3% to ¥1,474 million.」
While net sales reached a record high, operating income and ordinary income declined due to increases in labor costs, relocation expenses, overseas certification testing, personnel costs and research and development expenses. - FY2025-H1Higher sales but lower profitAnnual report
「As a result, consolidated results for the first half progressed generally in line with plan, with net sales rising 5.1% year on year to ¥8,059 million. On the profit side, the cost of sales increased due to relocation associated with consolidation into the new production building and overseas certification testing. Selling, general and administrative expenses also increased due to higher personnel and research and development costs, as well as participation in a major trade show. Consequently, operating income fell 41.4% to ¥319 million, ordinary income declined 28.5% to ¥408 million, and interim net income attributable to owners of the parent decreased 33.1% to ¥262 million.」
While net sales increased 5.1% year on year, operating income and other profit measures declined due to higher costs associated with relocation to the new production building, overseas certification testing, personnel, research and development, and participation in a major trade show. - FY2024AdvancedAnnual report
「For the fiscal year, net sales rose 5.5% to ¥17,444 million. Operating income increased 7.2% to ¥1,768 million, ordinary income rose 6.7% to ¥1,849 million, and net income attributable to owners of the parent increased 6.1% to ¥1,292 million.」
The company reported higher sales and profit for the full fiscal year, driven by the recovery in production, capture of domestic demand, price revisions and lower manufacturing costs. - FY2024-Q3AdvancedAnnual report
「As a result, consolidated cumulative results for the first 9 months were as follows. Although difficulties procuring components continued in some areas, the recovery in production advanced, and net sales rose 9.7% year on year to ¥12,363 million. In addition to higher sales, improvements in the cost of sales ratio resulting from partial sales price revisions and efforts to reduce manufacturing costs drove operating income up 40.5% to ¥1,237 million, ordinary income up 39.1% to ¥1,281 million, and net income attributable to owners of the parent up 26.4% to ¥896 million.」
Against the backdrop of a recovery in production, price revisions and lower manufacturing costs, net sales, operating income, ordinary income and net income attributable to owners of the parent increased year on year. - FY2024-Q2AdvancedAnnual report
「As a result, consolidated cumulative results for the first half were as follows. Although difficulties procuring components continued in some areas, the recovery in production advanced, and net sales rose 7.2% year on year to ¥7,666 million. In addition to higher sales, improvements in the cost of sales ratio resulting from partial sales price revisions and efforts to reduce manufacturing costs drove operating income up 51.4% to ¥545 million, ordinary income up 53.2% to ¥570 million, and net income attributable to owners of the parent up 25.9% to ¥391 million.」
Production recovered despite the continued impact of difficulties procuring components in some areas, and net sales, operating income, ordinary income and net income attributable to owners of the parent increased year on year. - FY2024-Q1MitigatedAnnual report
「As a result, consolidated cumulative results for the first quarter were as follows. Production delayed by difficulties in procuring components was brought back on track, and the order backlog was reduced, driving net sales up 13.0% year on year to ¥3,685 million. In addition to higher sales, improvements in the cost of sales ratio resulting from partial sales price revisions and efforts to reduce manufacturing costs drove operating income up 167.6% to ¥266 million, ordinary income up 196.0% to ¥272 million, and net income attributable to owners of the parent up 169.9% to ¥181 million.」
Bringing delayed production back on track and reducing the order backlog amid difficulties procuring components increased sales, while price revisions and lower production costs also contributed to substantial increases in operating income and other profit measures. - FY2023WorsenedAnnual report
「Amid record-high orders in the measuring instruments business, net sales rose 0.7% to ¥16,540 million for the fiscal year, despite the impact of longer lead times for component procurement. Due to higher component prices, a higher cost ratio resulting from the weaker yen, and increased sales promotion expenses, operating income declined 13.6% to ¥1,649 million.」
Despite record-high orders, supply constraints and higher costs limited sales growth and reduced operating income and other profit measures. - FY2023-Q3RestatedAnnual report
「As a result, consolidated cumulative results for the first 9 months were as follows. Orders remained strong, but production was significantly affected by longer lead times for component procurement, preventing the recognition of sales, and net sales fell to ¥11,269 million, down 4.4% year on year. Due to higher component prices, a higher cost ratio resulting from the weaker yen, and increases in sales promotion and research and development expenses, operating income declined 36.1% to ¥880 million, ordinary income fell 35.1% to ¥921 million, and net income attributable to owners of the parent decreased 26.3% to ¥709 million.」
Despite strong orders, supply constraints prevented the recognition of sales, and declines in sales and profit continued. - FY2023-Q2Continued decline in revenue and profitAnnual report
「As a result, consolidated cumulative results for the first half were as follows. Production was significantly affected by longer lead times for component procurement, and net sales fell to ¥7,154 million, down 3.8% year on year. Due to higher component prices, a higher cost ratio resulting from the weaker yen, and increases in sales promotion and research and development expenses, operating income declined 43.8% to ¥360 million, ordinary income fell 44.7% to ¥372 million, and net income attributable to owners of the parent decreased 33.2% to ¥311 million.」
Against the backdrop of longer lead times for component procurement, higher costs and increased expenses, net sales, operating income, ordinary income and net income declined year on year. - FY2023-Q1WorsenedAnnual report
「As a result, consolidated cumulative results for the first quarter were as follows. Production was significantly affected by difficulties in procuring components, and net sales fell to ¥3,262 million, down 1.9% year on year. Due to higher component prices, a higher cost ratio resulting from the weaker yen, and increases in sales promotion and research and development expenses, operating income declined 51.8% to ¥99 million, ordinary income fell 57.9% to ¥92 million, and net income attributable to owners of the parent decreased 51.5% to ¥67 million.」
Following higher sales and profit in FY2022, net sales, operating income, ordinary income and net income declined year on year against the backdrop of difficulties procuring components, higher costs and increased expenses. - FY2022AdvancedAnnual report
「For the fiscal year, net sales rose to ¥16,424 million, up 2.7% year on year. Operating income increased 3.1% to ¥1,909 million, and ordinary income rose 3.2% to ¥1,968 million.」
The fiscal year ending March 2022 saw higher sales, higher operating income and higher ordinary income. However, net income attributable to owners of the parent was ¥1,347 million, down 2.0% from the previous fiscal year, while ROE was 7.2%. - FY2022-Q3AdvancedAnnual report
「As a result, consolidated cumulative results for the first 9 months were as follows. Net sales rose to ¥11,787 million, up 4.8% year on year, while orders remained above the pace of sales growth. Operating income increased 14.2% to ¥1,377 million, ordinary income rose 13.4% to ¥1,419 million, and net income attributable to owners of the parent increased 9.7% to ¥963 million.」
Following the decline in sales and increase in profit in the year-earlier period, net sales, operating income, ordinary income and net income attributable to owners of the parent all increased year on year, resulting in higher sales and profit. - FY2022-Q2Continued revenue and profit growthAnnual report
「As a result, consolidated cumulative results for the first half were as follows. Net sales rose to ¥7,434 million, up 4.9% year on year, while orders remained at a high level, growing substantially faster than sales. Operating income increased 3.4% to ¥640 million, ordinary income rose 4.2% to ¥673 million, and net income attributable to owners of the parent increased 6.4% to ¥465 million.」
The company continued to report increases in both sales and profit, following the decline in sales and increase in profit in the year-earlier period. Net sales, operating income, ordinary income and net income attributable to owners of the parent all increased year on year. Orders remained at a high level, growing substantially faster than sales. - FY2022-Q1Higher revenue and profitAnnual report
「As a result, consolidated cumulative results for the first quarter were as follows. Net sales rose to ¥3,325 million, up 6.1% year on year. Operating income increased 9.0% to ¥206 million, ordinary income rose 8.5% to ¥219 million, and net income attributable to owners of the parent increased 16.8% to ¥138 million.」
After a decline in sales and an increase in profit in the year-earlier period, net sales, operating income, ordinary income and net income attributable to owners of the parent all increased year on year in the current quarter. - FY2021-Q3Lower Revenue; Higher ProfitAnnual report
「As a result, consolidated cumulative results for the first 9 months were as follows. Net sales fell to ¥11,243 million, down 2.6% year on year. Operating income increased 4.2% to ¥1,207 million, ordinary income rose 2.8% to ¥1,251 million, and net income attributable to owners of the parent increased 4.5% to ¥877 million. This reflected efforts to reduce production costs and expenses, as well as lower expenses resulting from restrictions on sales activities, including travel and transportation expenses and the cancellation of various trade shows due to the COVID-19 pandemic.」
While net sales declined 2.6% year on year, operating income, ordinary income and net income attributable to owners of the parent all increased year on year. - FY2021-Q2Lower sales, higher operating income; lower ordinary income, higher net incomeAnnual report
「As a result, consolidated cumulative results for the first half were as follows. Net sales fell to ¥7,085 million, down 5.3% year on year. Operating income increased 3.1% to ¥619 million, ordinary income declined 0.8% to ¥646 million, and net income attributable to owners of the parent increased 9.8% to ¥438 million. This reflected efforts to reduce production costs and expenses, as well as lower expenses resulting from restrictions on sales activities, including the cancellation of various trade shows due to the COVID-19 pandemic.」
While net sales declined 5.3% year on year, operating income and net income attributable to owners of the parent increased 3.1% and 9.8%, respectively, while ordinary income declined 0.8%. - FY2021-Q1Higher profit despite lower revenueAnnual report
「As a result, consolidated cumulative results for the first quarter were as follows. Net sales fell to ¥3,133 million, down 6.0% year on year. Operating income increased 28.6% to ¥189 million, ordinary income rose 19.7% to ¥201 million, and net income attributable to owners of the parent increased 106.4% to ¥118 million. This reflected efforts to reduce production costs and expenses, as well as lower expenses resulting from restrictions on sales activities, including the cancellation of various trade shows due to the COVID-19 pandemic.」
While net sales declined 6.0% year on year, operating income, ordinary income and net income attributable to owners of the parent all increased year on year. - FY2020-Q3WorsenedAnnual report
「As a result, consolidated cumulative results for the first 9 months were as follows. Due mainly to the negative impact of having recognized revenue from large projects in Asia in the year-earlier period, net sales fell to ¥11,538 million, down 10.6% year on year. Operating income declined 20.6% to ¥1,158 million, ordinary income fell 18.3% to ¥1,217 million, and net income attributable to owners of the parent decreased 16.7% to ¥840 million.」
Against the backdrop of the negative impact of large projects in Asia in the year-earlier period, net sales, operating income, ordinary income and net income attributable to owners of the parent declined year on year. - FY2020-Q2WorsenedAnnual report
「As a result, consolidated cumulative results for the first half were as follows. Due mainly to the negative impact of having recognized revenue from large projects in Asia in the year-earlier period, net sales fell to ¥7,482 million, down 12.1% year on year. Operating income declined 30.8% to ¥601 million, ordinary income fell 26.3% to ¥651 million, and net income attributable to owners of the parent decreased 30.4% to ¥398 million.」
Against the backdrop of lower overseas sales following the negative impact of large projects in Asia in the year-earlier period, net sales, operating income, ordinary income and net income attributable to owners of the parent declined year on year. - FY2020-Q1WorsenedAnnual report
「As a result, consolidated cumulative results for the first quarter were as follows. Due to a decline in overseas sales following the end of the special demand for China-bound exports in the year-earlier period, net sales fell to ¥3,333 million, down 17.9% year on year. Operating income declined 59.0% to ¥147 million, ordinary income fell 53.4% to ¥168 million, and net income attributable to owners of the parent decreased 72.0% to ¥57 million.」
Against the backdrop of lower overseas sales following the end of special demand for China-bound exports, net sales, operating income, ordinary income and net income attributable to owners of the parent declined year on year. - FY2019-Q3AdvancedAnnual report
「As a result, consolidated cumulative results for the first 9 months were as follows. Driven by a substantial increase in exports of the company's core environmental and process analyzers to China, steady progress in domestic sales and expanded production of medical-related equipment, net sales rose to ¥12,900 million, up 20.4% year on year. Operating income increased 47.4% to ¥1,459 million, ordinary income rose 45.1% to ¥1,490 million, and net income attributable to owners of the parent increased 45.9% to ¥1,008 million.」
Against the backdrop of increased exports to China, domestic sales and expanded production of medical-related equipment, net sales were ¥12,900 million, operating income was ¥1,459 million, ordinary income was ¥1,490 million, and net income attributable to owners of the parent was ¥1,008 million, all up year on year. - FY2019-Q2AdvancedAnnual report
「As a result, consolidated cumulative results for the first half were as follows. Driven by a substantial increase in exports of the company's core environmental and process analyzers to China, steady progress in domestic sales and expanded production of medical-related equipment, net sales rose to ¥8,515 million, up 25.6% year on year. Operating income increased 58.3% to ¥868 million, ordinary income rose 52.9% to ¥883 million, and net income attributable to owners of the parent increased 59.7% to ¥572 million.」
Against the backdrop of increased exports to China, domestic sales and expanded production of medical-related equipment, net sales, operating income, ordinary income and net income attributable to owners of the parent increased year on year. - FY2019-Q1AdvancedAnnual report
「For the first quarter of the fiscal year, consolidated cumulative results were as follows. Driven by a substantial increase in exports of the company's core environmental and process analyzers to China, steady progress in domestic sales and expanded production of medical-related equipment, net sales rose to ¥4,058 million, up 31.3% year on year. Operating income increased 101.7% to ¥359 million, ordinary income rose 95.7% to ¥361 million, and net income attributable to owners of the parent increased 179.1% to ¥204 million.」
Against the backdrop of increased exports to China, domestic sales and expanded production of medical-related equipment, net sales, operating income, ordinary income and net income attributable to owners of the parent increased year on year. - FY2018AdvancedAnnual report
「In terms of profit, efforts to strengthen the company's business foundation through higher sales, cost reductions and improved productivity resulted in operating profit of ¥1,704 million, up 24.9% year on year; ordinary profit of ¥1,765 million, up 23.7%; and net income attributable to owners of the parent of ¥1,230 million, up 0.3%. All three figures reached record highs.」
Against the backdrop of efforts to strengthen the company's operating base, operating income, ordinary income and net income attributable to owners of the parent all reached record highs. - FY2016First statedAnnual report
「Company-wide reform initiatives produced tangible results, while the financial position also improved and strengthened substantially, bringing the company to a stage of management stability.」
Expressed the company's view that it had reached a stage of management stability as a result of company-wide reform and improvements to its financial position.